Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Jul 29;356(9227):398-9.
doi: 10.1016/S0140-6736(00)02534-4.

Opioid Use in Last Week of Life and Implications for End-Of-Life Decision-Making

Opioid Use in Last Week of Life and Implications for End-Of-Life Decision-Making

A Thorns et al. Lancet. .

Abstract

This study was prompted by public and professional concern that the use of opioids for symptom control might shorten life. We retrospectively analysed the pattern of opioid use in the last week of life in 238 consecutive patients who died in a palliative care unit. Median doses of opioid were low (26.4 mg) in the last 24 h of life and patients who received opioid increases at the end of life did not show shorter survival than those who received no increases. The doctrine of double effect therefore need not be invoked to provide symptom control at the end of life.

Similar articles

See all similar articles

Cited by 32 articles

See all "Cited by" articles
Feedback